Upcoming COVID Vaccines Cmte. May Be More For Public Education Than Advising US FDA

 
• By Derrick Gingery

Agenda for Thursday’s meeting on coronavirus vaccine development and approval includes lots of background, which may help public confidence, but not necessarily FDA assessors as they weigh the tough decisions ahead of them.

FDA Advisory Committee Feature image
The discussion and recommendation portion of the meeting is the last item on the agenda. • Source: Pink Sheet illustration

More from Vaccines

More from Pink Sheet